Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes

6Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Background: Insulin aspart (IAsp) and its biphasic preparations BIAsp50 and BIAsp70 (containing 50% and 70% IAsp, respectively) have distinct glucose-lowering properties as compared to human insulin (HI). We investigated whether this affected the circulating IGF-system which depends on the hepatic insulin exposure.Methods: In a randomized, four-period crossover study, 19 patients with type 1 diabetes received identical doses (0.2 U/kg sc) of IAsp, BIAsp70, BIAsp50 and HI together with a standardized meal. Serum total IGF-I and IGFBP-1 to -3 were measured by immunoassays for nine hours post-prandially. Bioactive IGF was determined by an in-house, cell-based IGF-I receptor kinase activation (KIRA) assay.Results: Despite marked differences in peripheral insulin concentrations and plasma glucose, the four insulin preparations resulted in parallel decreases in IGFBP-1 levels during the first 3 hours, and parallel increases during the last part of the study (3-9 hours). Thus, only minor significances were seen. Insulin aspart and human insulin resulted in a lower area under the curve (AUC) during the first 3 hours as compared to BIAsp70 (p = 0.009), and overall, human insulin resulted in a lower IGFBP-1 AUC than BIAsp70 (p = 0.025). Nevertheless, responses and AUCs of bioactive IGF were similar for all four insulin preparations. Changes in levels of bioactive IGF were inversely correlated to those of IGFBP-1, increasing during the first 3 hours, whereafter levels declined (-0.83 ≤ r ≤ -0.30; all p-values <0.05).Total IGF-I and IGFBP-3 remained stable during the 9 hours, whereas IGFBP-2 changed opposite of IGFBP-1, increasing after 3-4 hours whereafter levels gradually declined. The four insulin preparations resulted in similar profiles and AUCs of total IGF-I, IGFBP-2 and IGFBP-3.Conclusions: Despite distinct glucose-lowering properties, the tested insulin preparations had similar effects on IGF-I concentration and IGF bioactivity, IGFBP-2 and IGFBP-3 as compared to HI; only small differences in IGFBP-1 were seen and they did not affect bioactive IGF. Thus, insulin aspart containing preparation behaves as HI in regards to the circulating IGF-system. However, bioactive IGF appeared to be more sensitive to insulin exposure than total IGF-I. The physiological significance of this finding remains to be determined.Trial registration: NCT00888732. © 2014 Ma et al.; licensee BioMed Central Ltd.

Author supplied keywords

References Powered by Scopus

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

0
23940Citations
N/AReaders
Get full text

Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions

1013Citations
N/AReaders
Get full text

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

713Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience

34Citations
N/AReaders
Get full text

Protamine coated proliposomes of recombinant human insulin encased in Eudragit S100 coated capsule offered improved peptide delivery and permeation across Caco-2 cells

24Citations
N/AReaders
Get full text

Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes

24Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ma, Z., Christiansen, J. S., Laursen, T., Wu, C., Lauritzen, T., Parkner, T., & Frystyk, J. (2014). Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes. BMC Endocrine Disorders, 14. https://doi.org/10.1186/1472-6823-14-35

Readers' Seniority

Tooltip

Researcher 5

45%

PhD / Post grad / Masters / Doc 4

36%

Professor / Associate Prof. 2

18%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

50%

Nursing and Health Professions 3

25%

Biochemistry, Genetics and Molecular Bi... 2

17%

Social Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free